character
antigen
epitop
hemagglutinin
ha
protein
influenza
viru
panel
consist
clone
murin
monoclon
antibodi
mab
gener
use
ha
protein
pandem
vaccin
lysat
season
influenza
vaccin
thirtythre
mab
found
strainspecif
mab
subtypespecif
twenti
mab
recogn
common
ha
epitop
share
pandem
season
influenza
virus
twentyf
clone
recogn
common
ha
epitop
share
pandem
season
human
influenza
virus
avian
influenza
virus
found
clone
mab
panel
crossreact
human
respiratori
pathogen
made
use
ha
season
viru
made
use
ha
pandem
influenza
viru
immunohistochem
analysi
tissu
microarray
tma
show
mab
clone
crossreact
human
tissu
brain
pancrea
result
indic
influenza
viru
ha
antigen
epitop
induc
type
subtyp
strainspecif
monoclon
antibodi
influenza
viru
also
crossreact
monoclon
antibodi
human
tissu
investig
crossreact
heterophil
epitop
may
significantli
improv
understand
viral
antigen
variat
epidem
pathophysiolog
mechan
advers
effect
influenza
vaccin
influenza
viru
iav
possess
capac
infect
human
mammal
bird
poultri
caus
consider
health
econom
threat
global
webster
et
al
iav
belong
orthomyxovirida
famili
singl
strand
neg
sens
rna
viru
eight
rna
segment
encod
least
protein
hemagglutinin
ha
encod
fourth
rna
segment
major
membran
glycoprotein
mediat
viral
attach
fusion
determin
pathogen
virul
neuraminidas
na
encod
sixth
rna
fragment
second
major
membran
glycoprotein
ha
na
crucial
antigen
compon
viru
due
immun
select
pressur
low
fidel
rna
transcript
rna
reassort
viral
genom
varieti
genet
immunogen
ha
na
variant
emerg
constantli
ha
na
subtyp
type
influenza
viru
identifi
tong
et
al
centuri
pandem
influenza
viru
emerg
mexico
quickli
spread
world
first
year
infect
alon
caus
death
estim
million
case
pandem
strain
number
sever
case
young
adult
without
underli
diseas
cdcgov
peopl
higher
risk
seriou
complic
includ
elderli
year
younger
children
pregnant
women
sever
case
symptom
includ
pneumonia
respiratori
failur
thrombocytopenia
death
desdouit
et
al
guedj
et
al
http
elsevi
gmbh
right
reserv
mamma
et
al
vaccin
best
prevent
strategi
influenza
safeti
efficaci
vaccin
pandem
strain
evalu
liang
et
al
advers
event
associ
vaccin
rais
concern
affect
largescal
administr
influenza
vaccin
cdc
william
et
al
choe
et
al
guillainbarr
syndrom
one
sever
advers
event
observ
vaccin
vaccin
deek
et
al
greenberg
et
al
howev
patholog
mechan
underli
influenza
viru
infect
vaccineinduc
seriou
advers
reaction
still
poorli
understood
monsalvo
et
al
found
nonprotect
antibodi
sera
patient
sever
pandem
influenza
diseas
nonprotectiveantibodi
found
associ
immun
complex
hypothes
autoimmun
play
role
develop
sever
symptom
viru
infect
vaccinationrel
advers
event
ahm
et
al
perdanpirkmaj
et
al
howev
evid
requir
support
hypothesi
studi
mechan
microbi
infect
immun
reveal
presenc
heterophil
antigen
also
call
molecular
mimicri
associ
pathogen
microorganismtrigg
infect
exampl
share
antigen
identifi
hemolyt
streptococcu
polysaccharid
protein
human
glomerular
basement
membran
antistreptococc
antibodi
produc
upon
hemolyt
streptococci
infect
bind
glomerular
basement
membran
caus
glomerulonephr
krau
beachey
moreov
antigen
share
escherichia
coli
type
lipopolysaccharid
human
colon
mucosa
relat
pathogenesi
ulcer
coliti
caus
e
coli
laercrantz
et
al
antiautoantibodi
also
identifi
lung
tissu
patient
atyp
pneumonia
infect
coronaviru
li
et
al
addit
role
receptor
bind
fusion
assembl
influenza
viru
ha
also
major
antigen
determin
induc
adapt
immun
respons
host
specul
influenza
viru
ha
human
tissuescel
common
heterophil
epitop
could
induc
heterophil
antibodi
respons
infect
host
heterophil
antibodi
may
involv
pathogen
influenza
viru
infect
mechan
vaccineinduc
advers
reaction
provid
evid
hypothesi
clone
monoclon
antibodi
gener
use
ha
protein
influenza
vaccin
lysat
season
vaccin
crossreact
mab
differ
subtyp
influenza
viru
respiratori
pathogen
human
tissu
evalu
result
suggest
share
epitop
influenza
viru
ha
antigen
certain
respiratori
pathogen
human
tissu
studi
crossreact
epitop
ha
protein
significantli
improv
understand
epitop
evolut
viru
epidem
pathophysiolog
mechan
infect
vaccineinduc
advers
event
immunogen
chemic
ltd
dalian
china
respiratori
pathogen
respiratori
syncyti
viru
rsv
parainfluenza
viru
adenoviru
adv
mycoplasma
pneumonia
chlamydia
pneumonia
purchas
bio
co
ltd
shenzhen
fei
peng
mous
myeloma
cell
purchas
atcc
balbc
mice
week
old
femal
purchas
experiment
anim
center
fourth
militari
medic
univers
hrplabel
goat
antimous
secondari
antibodi
purchas
zhongshan
golden
bridg
compani
polyethylen
glycol
peg
purchas
sigma
mab
subtyp
identif
kit
sba
clonotypingtm
systemhrp
obtain
southern
biotech
inc
hat
cell
cultur
medium
bovin
serum
dmem
purchas
gibco
human
tissu
chip
purchas
shaanxi
chaoy
biotech
co
tissu
immunohistochem
stain
kit
purchas
beij
zhongshan
golden
bridg
biotechnolog
co
ltd
experiment
mice
fed
steril
water
feed
mice
week
old
immun
g
antigen
vaccin
lysat
season
influenza
intraperiton
rout
ml
pb
emulsifi
equal
amount
freund
complet
adjuv
booster
immun
administ
intraperiton
dose
emulsifi
freund
incomplet
adjuv
hybridoma
cell
fusion
screen
clone
carri
accord
previous
publish
protocol
naundorf
et
al
briefli
spleen
cell
immun
mice
fuse
myeloma
cell
ratio
spleen
sp
fuse
cell
mix
allow
prolifer
hypoxanthin
aminopterin
thymidin
hat
supplement
medium
plate
incub
co
day
c
water
bath
ad
ml
fusogen
stir
cell
cell
allow
stand
cfor
ml
serumfre
dmem
ad
total
ml
serumfre
dmem
final
ad
termin
integr
effect
fuse
agent
centrifug
cell
supernat
discard
ml
hat
medium
slowli
ad
cell
subsequ
cell
resuspend
gentli
plate
preprepar
plate
lwell
fusion
cell
fusion
medium
chang
everi
day
day
day
half
medium
replac
hat
select
medium
day
day
medium
replac
ht
cultur
medium
fuse
cell
prolifer
settl
bottom
well
posit
antibodysecret
cell
screen
via
indirect
elisa
use
ha
protein
posit
cell
subclon
use
limit
dilut
method
purifi
subclon
time
establish
stabl
hybridoma
cell
line
stabl
line
cultur
frozen
c
futur
use
isotyp
mab
perform
isotyp
kit
sba
clonotyp
tm
systemhrp
accord
instruct
manual
indirect
elisa
conduct
specif
test
mab
reactiv
mab
influenza
viru
ha
vaccin
season
influenza
vaccin
avian
influenza
rsv
adv
pneumonia
c
pneumonia
evalu
allanto
fluid
cell
use
neg
control
ha
hi
test
perform
accord
previous
publish
protocol
yin
liu
serial
dilut
viru
season
influenza
viru
plate
ubottom
microtit
plate
lwell
equal
volum
chicken
erythrocyt
incub
cell
c
h
ha
titer
viru
measur
hi
test
l
ha
unit
differ
subtyp
influenza
viru
l
serial
dilut
mab
mixtur
ad
well
ubottom
microtit
plate
mix
well
incub
c
min
next
step
l
chicken
erythrocyt
ad
well
mix
well
incub
c
min
hi
titer
determin
highest
dilut
viru
prevent
hemagglutin
crossreact
ha
mab
human
tissu
examin
via
immunohistochem
stain
tissu
histolog
section
briefli
paraffin
section
tissu
deparaffin
hydrat
block
endogen
peroxidas
room
temperatur
min
h
block
buffer
contain
goat
serum
min
sampl
stain
primari
antibodi
mab
c
overnight
kept
room
temperatur
min
wash
time
pb
incub
hrplabel
sheep
antimous
secondari
antibodi
c
min
wash
pb
diaminobenzidin
dab
hematoxylin
ad
color
develop
color
enhanc
respect
accord
manufactur
instruct
total
g
ha
sampl
mgml
obtain
vaccin
lysat
mix
sd
electrophoresi
sampl
buffer
resolv
sdspage
gel
transfer
onto
nitrocellulos
membran
block
skim
milk
membran
treat
mab
supernat
membran
probe
hrplink
antimous
polyclon
secondari
antibodi
band
visual
via
chemiluminesc
use
ecl
reagent
use
convent
hybridoma
technolog
panel
clone
murin
monoclon
antibodi
gener
use
ha
protein
pandem
vaccin
lysat
season
influenza
vaccin
total
mab
clone
pandem
vaccin
lysat
mab
clone
season
influenza
vaccin
lysat
subcultur
three
month
hybridoma
cell
line
still
found
stabli
secret
antibodi
hybridoma
cell
line
frozen
liquid
nitrogen
found
grow
well
least
three
month
recoveri
continu
secret
consist
level
antibodi
light
chain
mab
clone
obtain
found
chain
wherea
igm
account
larg
proport
igm
iga
total
heavi
chain
sixti
three
percent
mab
hi
activ
see
tabl
detail
characterist
elisa
perform
determin
specif
crossreact
mab
influenza
viru
vaccin
season
influenza
viru
vaccin
avian
flu
vaccin
allanto
fluid
ascit
use
neg
control
base
reaction
differ
subtyp
influenza
viru
antigen
mab
divid
four
categori
strainspecif
mab
b
subtypespecif
mab
c
mab
season
influenza
virus
antigen
mab
common
influenza
viru
antigen
share
influenza
vaccin
season
vaccin
avian
influenza
vaccin
tabl
result
shown
tabl
conclud
strainspecif
mab
vaccin
eight
hi
activ
strainspecif
mab
season
vaccin
hi
activ
second
categori
includ
specif
mab
subtyp
influenza
viru
ha
protein
account
panel
four
hi
activ
third
categori
includ
mab
reactiv
ha
epitop
influenza
season
influenza
viru
account
total
mab
eight
mab
hi
activ
antibodi
fourth
categori
specif
ha
protein
epitop
share
season
avian
influenza
vaccin
account
panel
hi
activ
crossreact
test
use
elisa
mab
found
differ
degre
crossreact
parainfluenza
respiratori
syncyti
viru
adenoviru
pneumonia
c
pneumonia
mab
season
antigen
one
antigen
tabl
crossreact
mab
human
tissu
screen
via
microarray
immunohistochem
stain
result
show
four
mab
clone
crossreact
human
tissu
react
human
brain
tissu
pancreat
tissu
see
tabl
monoclon
antibodi
react
tissu
cerebr
cortex
nucleu
horni
wherea
react
islet
cell
fig
four
mab
crossreact
human
tissu
test
use
western
blot
analysi
fig
show
mab
crossreact
human
tissu
react
ha
protein
influenza
viru
applic
monoclon
antibodi
made
possibl
studi
individu
antigen
antibodi
molecul
depth
till
date
applic
monoclon
antibodi
influenza
viru
mainli
concentr
diagnosi
immunotherapi
prophylaxi
patholog
mechan
underli
sever
symptom
pandem
influenza
viru
infect
sever
advers
event
vaccin
still
poorli
understood
panel
clone
murin
monoclon
antibodi
mab
success
gener
use
ha
protein
pandem
vaccin
lysat
season
influenza
vaccin
among
clone
mab
obtain
made
influenza
vaccin
exampl
asouth
season
influenza
vaccin
add
inform
forti
six
mab
found
belong
igm
polysaccharid
antigen
known
easili
elicit
igm
antibodi
suggest
antibodi
panel
might
specif
polysaccharid
epitop
glycoprotein
result
mab
character
tabl
suggest
follow
differ
strainspecif
ha
epitop
pandem
season
influenza
virus
ii
pandem
season
influenza
virus
share
common
subtyp
epitop
iii
pandem
season
influenza
virus
share
common
epitop
iv
share
ha
epitop
pandem
season
avian
influenza
virus
mab
show
crossreact
pandem
season
avian
influenza
virus
hi
activ
suggest
categori
ab
endow
heterosubtyp
neutral
activ
potenti
applic
design
univers
prophylact
therapeut
tool
corti
et
al
interestingli
immunohistochem
stain
tabl
reveal
mab
clone
differ
degre
bind
affin
brain
pancrea
human
tissu
result
suggest
antigen
mimic
heterophil
antigen
epitop
share
influenza
viru
ha
protein
human
tissu
brain
pancrea
heterophil
antigen
epitop
capabl
induc
autoimmun
host
may
involv
patholog
mechan
underli
influenza
viru
infect
vaccinetrigg
advers
event
base
previou
studi
heterophil
antigen
epitop
share
pathogen
microorgan
human
tissu
krau
beachey
laercrantz
et
al
propos
autoimmun
induc
influenza
ha
protein
might
play
role
pathogenesi
associ
influenza
viru
infect
vaccin
carlo
garzelli
et
al
found
monoclon
antibodi
secret
epsteinbarr
virustransform
lymphocyt
could
react
multipl
organ
includ
thyroid
pancrea
stomach
muscl
nerv
indic
epsteinbarr
viru
induc
autoantibodi
naundorf
et
al
srinivasappa
et
al
report
mab
clone
prepar
use
viral
antigen
abl
react
differ
organ
normal
uninfect
mice
approxim
mab
react
specif
type
cell
organ
therefor
viral
infect
might
stimul
autoimmun
reaction
widespread
implement
influenza
vaccin
program
effect
prevent
strategi
help
highrisk
popul
establish
immun
barrier
influenza
infect
howev
rare
sever
advers
event
guillainbarr
syndrom
largescal
vaccin
rais
concern
vellozzi
et
al
evan
et
al
two
mab
gener
studi
capabl
bind
human
brain
tissu
two
clone
may
use
tool
understand
whether
develop
guillainbarr
syndrom
relat
influenza
vaccin
addit
clone
found
react
human
islet
cell
data
publish
studi
suggest
autoimmun
might
induc
influenza
infect
vaccin
investig
patholog
mechan
influenza
infect
vaccineinduc
advers
event
use
crossreact
mab
current
underway
laboratori
summari
panel
mab
gener
use
ha
protein
pandem
season
influenza
viru
one
group
mab
crossreact
activ
pandem
season
avian
influenza
virus
potenti
applic
design
univers
prophylact
therapeut
strategi
interestingli
gener
four
mab
crossreact
human
tissu
could
provid
practic
tool
elucid
mechan
associ
influenza
infect
vaccineinduc
advers
event
conflict
interest
exit
submiss
manuscript
author
approv
manuscript
public
